A Primer on Diabetes for the Astute Podiatrist
1 Year Subscription
Thank you very much, wow thank you so much for a very warm welcome. Before we get started I do need to disclose something, I was the site PI for a study that was supported by Bayer. I didnï¿½t get any money but my division did. So, just for you to know. So, Iï¿½m going to talk to you a little bit about diabetes, some things have changed. Who in this room sees patients with diabetes? Show of hands, who in this room? Okay, who in this room is awake? Show of hands. Okay, now letï¿½s try this again, who in this room sees patients with diabetes? Ah hah, so Iï¿½d say close to a 100 %, alright. Letï¿½s try another thing, who in this room has ever diagnosed a brand new patient with diabetes? Yeah, still quite a few, and weï¿½re going to talk about just that. Because we, endocrinologist, need your help cause you are on the front lines of this diabetes epidemic.
What are you going to get out of this talk?
Well, youï¿½re not going to become the worldï¿½s expert in diabetes.
But you will get a pretty good idea of when to get suspicious, when to screen for diabetes, how to do it and what to do with your results.
And Iï¿½m going to present two real cases that were referred to me by a real podiatrist that show how we can work together. And that also show the kind of situations where you should get suspicious. Iï¿½m also going to work in the brand new recommendations by the American Diabetes Association that were published this month. And they are brand new, so, youï¿½ll hear it here first.
So letï¿½s try the first case. This is a 24 year old African American man who comes to see you for burning foot pain and he never goes to a doctor.
And, heï¿½s been feeling weak and lethargic.
Heï¿½s quite portly; he has a BMI of 38. Quite obese, right BMI, Body Mass Index of over 30 qualifies as obese. But, heï¿½s very proud because heï¿½s effortlessly lost 25 pounds over the past two months. And, I donï¿½t know if you have the Star Bucks phenomenal in your practice. My patients sip their coffee and theyï¿½re on their cell phones while they are seeing me. This patient is happily guzzling a quart of orange juice while heï¿½s seeing his doctor.
On examination you see that he has got no sense of vibration, on the other hand when you go for monofilament testing he jumps out of the chair.
So what should you not do?
Should you not ask him whether he is having polyurpathy, polydipsia or blurry vision?
Should you get a random blood sugar with a glucometer in your office? Weï¿½re going to talk about that in a moment.
Should you get a hemoglobin A1c test? Or maybe a urine dip stick?
Should you refer him to an internist?
Or should you offer him, kind podiatrist you are and excellent host, should you offer him another glass of OJ?
And, letï¿½s go for the second case. The second scenario of the typical diabetic I will present.
A 46 year old obsess Hispanic woman seeks your advice because sheï¿½s got yellow toenails, and sheï¿½s upset about it. And when you ask her about it she admits to having pins and needles in her feet.
She also asks you hey, do you know somebody that can take care of my extra facial hair in places where I donï¿½t really want it?
And she also tells you that everybody in her family has diabetes and she thought about it. So she checked her blood sugar with her grandmotherï¿½s meter and it was okay.
So what should you not do for this lady?
Should you get a point of care hemoglobin HbA1c test? Thatï¿½s a finger stick test that can tell you right on the spot the patientï¿½s hemoglobin A1c.
Should you refer her to a good internist?
Should you ask the patient what she considers okay?
Should you get an oral glucose tolerance test, where a patient goes and gets 75 grams of sugar solution and then sticks around for two hours so you can see what the blood sugar level is two hours later?
Or should you just give itraconazole cream and assure the patient that her yellow toenails will turn out fine?
Now letï¿½s talk about diabetes and weï¿½re going to get back to these two cases.
Itï¿½s extremely prevalent at this point if you go with the adult population, almost 13% of the population older than twenty has diabetes. Now Mount Sinai is adjacent to East Harlem, the quota there is 25%.
An additional close to 30% of the population would qualify as pre-diabetic. So they are on their way to having diabetes.
About a third to 40% are unaware that they have diabetes. They are undiagnosed.
And if you take the people already diagnosed with diabetes, around 20% of them will already have diabetic eye disease.
And around 10%, and those are the patients that you are seeing, will have diabetic neuropathy at the time of diagnosis.
And of course bad things happen to people with diabetes. So its not just the diabetic neuropathy that you are seeing,
Nephropathy leading to dialysis, retinopathy making diabetes the leading cause for blindness in the United States,
And macrovascular disease,
Which leads to premature death, which is why patients with diabetes will have a harder time getting life insurance, you know it literally shaves off seven years of your life.
And the number one factor is obesity as you can see your risk really skyrockets with body mass index. How whatï¿½s a normal body index? Anything from 19 to 25 is considered normal, 25 to 30 are considered over weight, and weï¿½re talking now about the Caucasian population, other populations itï¿½s even lower. And once you get over, and this is your body mass index, 30 in relation to your weight and your height, once you have a body mass index greater than 30 your risk factor for diabetes really skyrockets.
So who should get screened?
Anybody with a BMI greater than 25.
People that have first degree relatives that have diabetes, Type II Diabetes.
If a patient tells you she had gestational diabetes that means she has a ten year of going forward of 50% or greater of developing Type II Diabetes. Now some patients will not know if they had gestational diabetes or not because they never got screened, or they never cared. So, another question to ask is did you have any children at birth that were heavier than 9 pounds? Thatï¿½s a pretty good indicator that they had gestational diabetes.
Patients with hypertension.
Women with polyosytic ovarian disease. That extra facial hair in that lady who was obese. Absolutely a risk factor for diabetes.
Lipid profile disturbances.
Patients with pre-diabetes have obliviously a higher risk of progressing towards diabetes.
Patients with cardiovascular disease.
And actually anybody older than 45 has an increased risk towards diabetes and deserves to be screened.
So a good podiatrist should be able to diagnose diabetes and know that you in this room have done that. But, the guidelines have changed so I am here to update you.
You might already know to diagnosis diabetes a fasting sugar greater of 126 is sufficient.
Or a random sugar greater than 200 with symptoms. So in that first guy, the one in case number 1 who has the lethargy and the weight loss, and the polyurpathy, polydipsia, since you asked about it probably, if he has a random blood sugar greater than 200 thatï¿½s it. Thatï¿½s his diagnosis.
An oral glucose tolerance test that is greater than 200 after two hours and this is certainly the test that gives you the greatest sensitivity.
And finally, and this is new as of the guidelines from January, 2010, according to the HbA1c greater than 6.5%.
Now this is revolutionary because you donï¿½t need to be fasting, the hemoglobin A1c is your average blood sugar over the past three months. So thatï¿½s pretty neat, you can just do a blot test, the patient does not need to be fasting, you know, we all know cause itï¿½s pretty hard to get people in fasting. And itï¿½s pretty hard to get people to sit still for two hours and sit in the lab. Cause nobody has time, I practice Manhattan, nobody has time to sit around for two hours. So this is a pretty neat alternative.
We spoke about pre-diabetes and pre-diabetes can be defined in two ways. Either youï¿½ve got impaired fasting glucose, meaning that you fasting glucose is in the range between 100 and 126 and thatï¿½s fasting. Or, you can have impaired glucose tolerance meaning that when a patient eats a meal with a certain carb content, blood sugar goes up disproportionably and this is on oral glucose tolerance test so normal is less than 140 and pre-diabetic is impaired glucose tolerance or IGT, is 140 to 200. And greater than 200 defines diabetes. And this is pretty neat because of an oral glucose tolerance test instead of a meal defines actually how much sugar they get so that makes the results more reproducible. Now again, I practice in Manhattan so itï¿½s hard to get people to sit still for two hours.
The ADA has new guidelines which defines pre-diabetes as an A1c between 5.7 and 6.4%. And again, this is pretty nifty because they donï¿½t have to be fasting, they donï¿½t have to stick around for two hours. You can just do a blood draw and send it to a lab. Or, you can do a point of care test and these kits are around eight dollars per test and Medicare reimburses it depending on what state you live in, at around thirteen dollars, something like that. So, you can actually make the diagnosis of diabetes in your office just by asking two or three smart questions and by getting one simple blood test. So what I think is very appropriate to have is a non-coding glucometer, meaning you donï¿½t have to put in a new code every time you buy a new batch of test strips. You know you can get a good glucometer at any department store for less than twenty bucks, test strips are fifty cents per test strip, and you can make the diagnosis right there in your practice. Itï¿½s pretty easy.
So you donï¿½t really have to worry if your patient has a touch of sugar, you can diagnose it. And youï¿½re at the forefront of this epidemic. A lot of patients will not come see me because they donï¿½t feel like they have diabetes; theyï¿½re going to come see you because they have trouble with their feet. And you can, beyond saving their feet, you can save their lives by diagnosing diabetes in a much more timely manner than I would by the time they come to me.
Now, I personally like the oral glucose tolerance test if you can do it because you have more sensitivity. Cause if you take just fasting glucose youï¿½ll miss a lot of the patients that have impaired glucose tolerance so I think that in my opinion the oral glucose tolerance test is the best test of diagnosing diabetes if your patients will allow you to do it.
And this is how I order it for Ms. Pie. You write a prescription for a glucose tolerance test, two hours and 75 grams and put the diagnosis on, give them the prescription and send them off to the lab. And if youï¿½re lucky they will do it. If you donï¿½t think they will do it just get an A1c, much quicker.
So letï¿½s talk about what happened to those two real patients.
The first one who was losing weight so effortlessly, he had a random blood sugar of 426.
He also had ketonuria, meaning that this was a candidate to actually be sent to the ER.
Instead, they drew an A1c, which you can see was quite elevated.
They e-mailed me, can you see this guy right now, which I did.
And I started him on insulinï¿½s and now heï¿½s on orals. A lot happier, heï¿½s feeling a lot less lethargic and so we caught it and heï¿½s doing a lot better now. And interestingly his neuropathy is also a little bit better.
So with the second patient it turns out that okay means different things to different people. Everybody in her family that had diabetes had uncontrolled diabetes so for her normal sugar was something like 200. And she was very excited that she had a fasting sugar in the 120ï¿½s.
And then an oral glucose tolerance test showed that she actually went higher.
Over 200 after two hours so she qualified as having diabetes. Sheï¿½s now very happy doing on a little bit of metformin and doing quite well with life style changes and this oral medication. And her paresthesias are also doing a little bit better.
So take home messages for this audience, for you.
Type 2 Diabetes is really common.
And you are at the forefront of the diabetes epidemic whether you like it or not, many of my potential patients never get to see me, they go to see you. And you have to think, could this person have diabetes and you have the opportunity to not just save their limb, but save their life.
So get a glucometer, ideally a non-coding one so that you have less hassle with it.
Consider point of care, hemoglobin A1c testing or blood draw if you have the time.\
And again, you can have a major impact by diagnosing diabetes earlier.
Thank you very much and now Iï¿½m open for questions.
|Goals and Objectives|
After participating in this activity, the viewer should be better able to:
1. Recognize the value of the podiatrist in recognition of undiagnosed diabetic patients.
2. Recognize when and how to screen for diabetes.
3. Demonstate what to do with the results of diabetes screening methods.
4. Analyze the use of HbA1c testing for screening of diabetes.
Estimated time to complete this activity is 24 minutes.
Physicians, diabetes educators, and other health care professionals who treat patients with diabetes.
Complete the 4 steps to earn CE/CME credit:
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.Ronald Tamler, MBA, MD, PhD, CNSP, CDE has no relevant financial relationship(s) to disclose.
This web site will respect the confidentiality of the information that is transmitted on it in accordance with the provisions of this Agreement. The Web Site uses a random identifier, which is a session number attributed to the Registered User as he enters the site. This session number is expunged of the Web Site system as Registered User leaves. Please be advised that the Registered User's visit to the Web Site leaves a retrievable trace that allows the Web Site to gather raw data on the Registered User. Such technical retrieving system is necessary in order to secure the Web Site system.
This web site uses statistic and measurement systems which compile and process information such as IP numbers and number of visited pages. This information is processed in order to establish members' profiles and trends that may lead to, for example, market studies.
By registering to Web Site services, the Registered User agrees that his/her personal information may be archived in the members database of the Web Site and be used to transmit newsletters published by the Web Site and communications such as press releases or commercial information by the Host.
Information We Collect
Information We Collect from Unregistered Visitors
Visitors to each of our Web sites can access the Web site's home page and browse some areas of the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you. On most of our Web sites, you must register with us to use the entire site.
Information We Collect When You Register
Customers registering for services on our Web sites are asked to provide us with identifying information, such as name, gender, contact information, and other personal information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion. You will also be given a choice about whether or not you want to receive newsletters and other information that we distribute from time to time. This PRESENT e-Learning Systems Web site will explain how personally identifiable information will be used and ask for your consent before collecting it.
Discussion Boards: When you use a discussion board on one of our Web sites, you may post a message and your user name, which is available for all registered users to see. When you are posting publicly, any user of our Web site can see your message. You should not post any information you want or are required by law to keep private to a discussion board or other public forum on our Web sites.
My CV (Curriculum Vitae): On our web site, we offer an online data based profiling tool in which you supply information that is part of your curriculum vitae or professional resume. This tool stores the information that you provide on our servers. The information is accessible by other members and the public, and is designed to advertise you to the online community and allow other's to find you based on the information that you provide. We will always make it clear to you when information you provide to us through a tool will be saved.
Member Lookup: On our website, other members will be able to look you up and send you messages. If you opt not to be listed (blocked), no other members will be able to look you up.
In addition, we gather information about you that is automatically collected by our Web server, such as your IP address and domain name. We will use this information to personalize its offerings and presentations to you, facilitate your movements throughout our Web sites, provide personalized services, and to communicate with you individually.
Continuing Medical Education
When you register for a Continuing Medical Education ("CME") or a Continuing Education ("CE") activity through our web site, we collect certain personally identifiable information from you such as your name, email address and mailing address. We require that you provide the state in which you are licensed and your license number. In addition to personally identifiable information, we collect aggregated non-personally identifiable information about the activities undertaken by our users. We use the information that we collect through CME/CE activities in several ways:
(i) We are accredited by the Accreditation Council for Continuing Medical Education ("ACCME") to provide continuing medical education for physicians, through a sponsorship agreement with the Mount Sinai School of Medicine. As an ACCME accredited entity, we are required periodically to submit aggregated data about CME participants and the CME activities we certify. We also provide personally identifiable information to other accredited CME/CE providers who certify CME/CE activities posted on our Web sites, as required by the ACCME and other accrediting bodies. These reports may include personally identifiable information about you and credits issued to you, for the purpose of maintaining records that you can request from the accredited provider for up to six (6) years;
(ii) Commercial supporters of CME/CE activities on our Web site will receive only a data about CME/CE activities that are relevant to their interests and/or the courses they support;
Uses We Make of Information
We collect data about visitors to our Web sites for product development and improvement activities. We also use it for market analysis. We may provide information from our Web sites in aggregate form, with identifying information removed, to third parties. For example, we may tell a health care partner what percentage of our registered users are of a particular medical specialty or have certain credentials. Any third party that receives our data must agree not to attempt to re-identify the people it belongs to. For example, we may provide information to a potential advertiser of a product that would appeal to a diabetes patient about what percentage of our users have diabetes. Depending on our agreement with the third parties, we may or may not charge for this information.
Marketing and Advertising
We may target our advertising or marketing depending on information we have about you. For example, a user that is a healthcare professional who treats diabetes may receive advertising for new diabetes therapies (although in neither case will the advertiser have access to any individually identifiable information about you). We may also personalize our Web site based on your interests. For example, you may see different articles in different places on our Web site based on information you have shared with us, or information we have gained by observing your previous behavior, or information we may have gained from your interactions with a third party that shares information with us. We use information for our own internal marketing, research, and related purposes. Third Parties In addition to aggregate information (discussed previously), we may share some kinds of personally identifiable information with third parties as described below.
Other Companies: We have strategic relationships with other companies who offer products and services on our Web sites. When you are interacting with those companies, different rules and privacy policies may apply. We do not control the collection or use of information you provide to these companies, but we do require that those companies clearly state their policies so you can decide whether to give them any information.
Promotional Offers: Sometimes we send offers to selected groups of customers on behalf of other businesses. When we do this, we do not give that business your name and address. We provide a variety of mechanisms for you to tell us you do not want to receive such promotional offers. For example, we may provide an opt-in box for consumers to receive an email from another business, and we make clear that by opting in you are submitting your data to a third party.
Protection of Information
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. We use security methods to determine the identity of its registered users, so that appropriate rights and restrictions can be enforced for that user. Reliable verification of user identity is called authentication. We use both passwords and usernames, as well as double opt-n verification, to authenticate users. Users are responsible for maintaining their own passwords.
Access to Information and Choices
Correction of Information We Have About You
If you believe that registration information collected by our Web site(s) is in error, you may edit your personal profile any time that you like. You can directly edit most of your user profile on the Web site on which you initially registered. Information that you can not edit may only be changed by contacting Web Customer Support (see CONTACTS). Requests for deletion of your record may result in your removal from the registry, but we may keep certain demographic information about you for product improvement purposes. You may contact Web Customer Support and ask for the changes that you would like to make.
This website and its content is copyright of PRESENT eLearning Systems, LLC - © 2007- All rights reserved. Any redistribution or reproduction of part or all of the contents in any form is prohibited other than the following:
You may not, except with our express written permission, distribute or commercially exploit the content. Nor may you transmit it or store it in any other website or other form of electronic retrieval system.